The petitioner seeks authorization to institute a class action on behalf of all persons in Quebec who were prescribed and who consumed the drug valsartan. The claim alleges that the drug had adverse side effects about which the respondents failed to warn. The certification of this matter has not yet been heard.
Fasken team acted for Sandoz Canada Inc., Pro Doc Limitée, Sanis Health Inc. and Sivem Pharmaceuticals ULC in this putative class action launched in Quebec and was composed of Peter Pliszka and Noah Boudreau.
